Evaluation of cases with over 10 years of follow-up after stereotactic body radiotherapy for Stage I lung cancer.
PURPOSE Stereotactic body radiotherapy (SBRT) is a well-established treatment for early stage non-small cell lung cancer (NSCLC); however, outcomes beyond 10 years remain poorly defined. We aimed to evaluate late toxicities, recurrence patterns, and secondary malignancies in patients with ≥10 years of follow-up after S...